Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Price to Earnings (P/E)
since 2019

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Shockwave Medical Inc., P/E, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Shockwave Medical Inc. Annual Report.


The analysis of the financial data reveals several notable trends over the five-year period ending February 26, 2024.

Share Price
The share price exhibited substantial growth over the analyzed period. Starting from a value of $29 in March 2020, it increased significantly to $259.89 by February 2024. This represents a nearly ninefold increase, highlighting strong market performance and investor confidence during this timeframe.
Earnings Per Share (EPS)
The EPS shows a marked improvement over the period. Initially, the company reported negative earnings per share, with a loss of $1.61 in March 2020, which further deteriorated slightly to -$1.89 in February 2021. However, from 2022 onwards, there is a positive turnaround; EPS rose to -$0.26 in February 2022, then sharply improved to $5.92 in February 2023, before slightly decreasing to $3.94 in February 2024. This positive trend signifies increasing profitability after a phase of losses, suggesting effective operational management and possible revenue growth.
Price-to-Earnings (P/E) Ratio
The P/E ratio data is only available for the last two years. It was 32.02 in February 2023 and substantially increased to 65.99 in February 2024. The rising P/E ratio suggests that the market's valuation of the company has grown relative to its earnings, possibly reflecting heightened investor expectations or speculative premium given the improved profitability.

Overall, the data indicates a company transitioning from a loss-making position towards profitability, accompanied by a remarkable increase in share price and elevated market valuation levels. The period from 2022 to 2024 is particularly notable for the sharp improvement in both earnings and stock market performance.


Comparison to Competitors

Shockwave Medical Inc., P/E, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Comparison to Sector (Health Care Equipment & Services)

Shockwave Medical Inc., P/E, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Comparison to Industry (Health Care)

Shockwave Medical Inc., P/E, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).